Jennifer Woyach, MD of The Ohio State University Comprehensive Cancer Center, Columbus, OH talks developments in chronic lymphocytic leukaemia (CLL) at the 2016 International Workshop of the German CLL Study Group (GCLLSG) in Cologne, Germany. Dr Woyach explains that this an exciting time for CLL as we are moving away from chemotherapy towards targeted therapies alone or in combination with expectation of good efficacy, good tolerability and hopefully long durations of remission.
From chemotherapy towards targeted therapies in CLL
